Dezhan Healthcare (000813.SZ) stated on the investor interaction platform on August 21 that Eaststrait ABC-3100 (also known as VGX-3100) is the world's first HPV therapeutic vaccine developed based on DNA technology platform.
德展健康(000813.SZ)：东方略ABC-3100是基于DNA技术平台开发的全球首款HPV治疗性疫苗
Dezhan Healthcare (000813.SZ): Eastern Strategy ABC-3100 is the world's first HPV therapeutic vaccine developed based on DNA technology.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.